Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size

Richard Lee, Takashi Nitta, Ralph A. Schmid, Richard B. Schuessler, Kevin M. Harris, William A. Gay

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background. Retrograde perfusion preserves ischemic myocardium when initiated shortly after coronary artery occlusion. However, benefits diminish as the delay increases. In this study, we used this technique to deliver agents known to reduce the injury associated with the reperfusion of ischemic myocardium. We proposed that the local delivery of lidocaine or L-arginine before reperfusion would reduce the damage caused during reperfusion, even after a delay between onset of ischemia and intervention designed to approximate clinical reality. Methods. In a porcine model of myocardial ischemia, the left anterior descending coronary artery was snared immediately distal to its second diagonal branch. After 1 hour of occlusion, 34 animals were randomized into six groups: no intervention (control) (n = 6); administration of normal saline solution into the great cardiac vein (Retro- NS) (n = 6); administration of lidocaine either intravenously (IV-LID) (n = 6) or retrograde (Retro-LID) (n = 6); and administration of L-arginine either intravenously (IV-L-ARG) (n = 5) or retrograde (Retro-L-ARG) (n = 5). After 90 minutes of ischemia, the snare was released, and the myocardium was reperfused for 3 hours. Two-dimensional echocardiograms were made prior to occlusion and 60, 150, 210, and 270 minutes after occlusion. The infarct size and the area at risk were determined by lissamine green and triphenyltetrazolium chloride staining with computer planimetric quantification. Regional wall motion was assessed by a wall motion score: normal = 1; mild hypokinesia = 2.0; severe hypokinesia = 2.5; and akinesia = 3. Results. The area of the left ventricle at risk for infarction was similar in all groups and represented 25.4% (5.2% [standard deviation]) of the left ventricular mass (p = 0.63). The percent area of infarction in the area at risk after 3 hours of reperfusion was 76.7% (7.1% for the control group, 73.9% (5.7%) for the Retro-NS group, 72.1% (8.7%) for the IV-LID group, 54.5% (10.2%) for the Retro-LID group, 58.8% (4.0%) for the IV-L-ARG group, and 54.3% (4.0%) for the Retro-L-ARG group p < 0.005, Retro-LID and Retro-L-ARG versus Control, Retro-NS, and IV-LID; p < 0.03, IV-L-ARG versus control and Retro-NS). No significant difference in wall motion scores between groups was detected by echocardiography (p = 0.578). Conclusions. Retrograde delivery of lidocaine or L-arginine before reperfusion reduces infarct size without acutely affecting wall motion after 90 minutes of ischemia and 3 hours of reperfusion. Lidocaine must be present before reperfusion to have an effect, whereas L-arginine is beneficial if it is delivered at the time of reperfusion.

Original languageEnglish (US)
Pages (from-to)1353-1359
Number of pages7
JournalAnnals of Thoracic Surgery
Volume65
Issue number5
DOIs
StatePublished - May 1 1998
Externally publishedYes

Fingerprint

Lidocaine
Reperfusion
Arginine
Myocardial Infarction
Hypokinesia
Myocardium
Ischemia
Infarction
Coronary Vessels
Coronary Occlusion
Sodium Chloride
Heart Ventricles
Myocardial Ischemia
Echocardiography
Veins
Swine
Perfusion
Staining and Labeling
Control Groups
Wounds and Injuries

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size. / Lee, Richard; Nitta, Takashi; Schmid, Ralph A.; Schuessler, Richard B.; Harris, Kevin M.; Gay, William A.

In: Annals of Thoracic Surgery, Vol. 65, No. 5, 01.05.1998, p. 1353-1359.

Research output: Contribution to journalArticle

Lee, Richard ; Nitta, Takashi ; Schmid, Ralph A. ; Schuessler, Richard B. ; Harris, Kevin M. ; Gay, William A. / Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size. In: Annals of Thoracic Surgery. 1998 ; Vol. 65, No. 5. pp. 1353-1359.
@article{fabc75502a194987a90765abfeb39b6a,
title = "Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size",
abstract = "Background. Retrograde perfusion preserves ischemic myocardium when initiated shortly after coronary artery occlusion. However, benefits diminish as the delay increases. In this study, we used this technique to deliver agents known to reduce the injury associated with the reperfusion of ischemic myocardium. We proposed that the local delivery of lidocaine or L-arginine before reperfusion would reduce the damage caused during reperfusion, even after a delay between onset of ischemia and intervention designed to approximate clinical reality. Methods. In a porcine model of myocardial ischemia, the left anterior descending coronary artery was snared immediately distal to its second diagonal branch. After 1 hour of occlusion, 34 animals were randomized into six groups: no intervention (control) (n = 6); administration of normal saline solution into the great cardiac vein (Retro- NS) (n = 6); administration of lidocaine either intravenously (IV-LID) (n = 6) or retrograde (Retro-LID) (n = 6); and administration of L-arginine either intravenously (IV-L-ARG) (n = 5) or retrograde (Retro-L-ARG) (n = 5). After 90 minutes of ischemia, the snare was released, and the myocardium was reperfused for 3 hours. Two-dimensional echocardiograms were made prior to occlusion and 60, 150, 210, and 270 minutes after occlusion. The infarct size and the area at risk were determined by lissamine green and triphenyltetrazolium chloride staining with computer planimetric quantification. Regional wall motion was assessed by a wall motion score: normal = 1; mild hypokinesia = 2.0; severe hypokinesia = 2.5; and akinesia = 3. Results. The area of the left ventricle at risk for infarction was similar in all groups and represented 25.4{\%} (5.2{\%} [standard deviation]) of the left ventricular mass (p = 0.63). The percent area of infarction in the area at risk after 3 hours of reperfusion was 76.7{\%} (7.1{\%} for the control group, 73.9{\%} (5.7{\%}) for the Retro-NS group, 72.1{\%} (8.7{\%}) for the IV-LID group, 54.5{\%} (10.2{\%}) for the Retro-LID group, 58.8{\%} (4.0{\%}) for the IV-L-ARG group, and 54.3{\%} (4.0{\%}) for the Retro-L-ARG group p < 0.005, Retro-LID and Retro-L-ARG versus Control, Retro-NS, and IV-LID; p < 0.03, IV-L-ARG versus control and Retro-NS). No significant difference in wall motion scores between groups was detected by echocardiography (p = 0.578). Conclusions. Retrograde delivery of lidocaine or L-arginine before reperfusion reduces infarct size without acutely affecting wall motion after 90 minutes of ischemia and 3 hours of reperfusion. Lidocaine must be present before reperfusion to have an effect, whereas L-arginine is beneficial if it is delivered at the time of reperfusion.",
author = "Richard Lee and Takashi Nitta and Schmid, {Ralph A.} and Schuessler, {Richard B.} and Harris, {Kevin M.} and Gay, {William A.}",
year = "1998",
month = "5",
day = "1",
doi = "10.1016/S0003-4975(98)00186-6",
language = "English (US)",
volume = "65",
pages = "1353--1359",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Retrograde infusion of lidocaine or L-arginine before reperfusion reduces myocardial infarct size

AU - Lee, Richard

AU - Nitta, Takashi

AU - Schmid, Ralph A.

AU - Schuessler, Richard B.

AU - Harris, Kevin M.

AU - Gay, William A.

PY - 1998/5/1

Y1 - 1998/5/1

N2 - Background. Retrograde perfusion preserves ischemic myocardium when initiated shortly after coronary artery occlusion. However, benefits diminish as the delay increases. In this study, we used this technique to deliver agents known to reduce the injury associated with the reperfusion of ischemic myocardium. We proposed that the local delivery of lidocaine or L-arginine before reperfusion would reduce the damage caused during reperfusion, even after a delay between onset of ischemia and intervention designed to approximate clinical reality. Methods. In a porcine model of myocardial ischemia, the left anterior descending coronary artery was snared immediately distal to its second diagonal branch. After 1 hour of occlusion, 34 animals were randomized into six groups: no intervention (control) (n = 6); administration of normal saline solution into the great cardiac vein (Retro- NS) (n = 6); administration of lidocaine either intravenously (IV-LID) (n = 6) or retrograde (Retro-LID) (n = 6); and administration of L-arginine either intravenously (IV-L-ARG) (n = 5) or retrograde (Retro-L-ARG) (n = 5). After 90 minutes of ischemia, the snare was released, and the myocardium was reperfused for 3 hours. Two-dimensional echocardiograms were made prior to occlusion and 60, 150, 210, and 270 minutes after occlusion. The infarct size and the area at risk were determined by lissamine green and triphenyltetrazolium chloride staining with computer planimetric quantification. Regional wall motion was assessed by a wall motion score: normal = 1; mild hypokinesia = 2.0; severe hypokinesia = 2.5; and akinesia = 3. Results. The area of the left ventricle at risk for infarction was similar in all groups and represented 25.4% (5.2% [standard deviation]) of the left ventricular mass (p = 0.63). The percent area of infarction in the area at risk after 3 hours of reperfusion was 76.7% (7.1% for the control group, 73.9% (5.7%) for the Retro-NS group, 72.1% (8.7%) for the IV-LID group, 54.5% (10.2%) for the Retro-LID group, 58.8% (4.0%) for the IV-L-ARG group, and 54.3% (4.0%) for the Retro-L-ARG group p < 0.005, Retro-LID and Retro-L-ARG versus Control, Retro-NS, and IV-LID; p < 0.03, IV-L-ARG versus control and Retro-NS). No significant difference in wall motion scores between groups was detected by echocardiography (p = 0.578). Conclusions. Retrograde delivery of lidocaine or L-arginine before reperfusion reduces infarct size without acutely affecting wall motion after 90 minutes of ischemia and 3 hours of reperfusion. Lidocaine must be present before reperfusion to have an effect, whereas L-arginine is beneficial if it is delivered at the time of reperfusion.

AB - Background. Retrograde perfusion preserves ischemic myocardium when initiated shortly after coronary artery occlusion. However, benefits diminish as the delay increases. In this study, we used this technique to deliver agents known to reduce the injury associated with the reperfusion of ischemic myocardium. We proposed that the local delivery of lidocaine or L-arginine before reperfusion would reduce the damage caused during reperfusion, even after a delay between onset of ischemia and intervention designed to approximate clinical reality. Methods. In a porcine model of myocardial ischemia, the left anterior descending coronary artery was snared immediately distal to its second diagonal branch. After 1 hour of occlusion, 34 animals were randomized into six groups: no intervention (control) (n = 6); administration of normal saline solution into the great cardiac vein (Retro- NS) (n = 6); administration of lidocaine either intravenously (IV-LID) (n = 6) or retrograde (Retro-LID) (n = 6); and administration of L-arginine either intravenously (IV-L-ARG) (n = 5) or retrograde (Retro-L-ARG) (n = 5). After 90 minutes of ischemia, the snare was released, and the myocardium was reperfused for 3 hours. Two-dimensional echocardiograms were made prior to occlusion and 60, 150, 210, and 270 minutes after occlusion. The infarct size and the area at risk were determined by lissamine green and triphenyltetrazolium chloride staining with computer planimetric quantification. Regional wall motion was assessed by a wall motion score: normal = 1; mild hypokinesia = 2.0; severe hypokinesia = 2.5; and akinesia = 3. Results. The area of the left ventricle at risk for infarction was similar in all groups and represented 25.4% (5.2% [standard deviation]) of the left ventricular mass (p = 0.63). The percent area of infarction in the area at risk after 3 hours of reperfusion was 76.7% (7.1% for the control group, 73.9% (5.7%) for the Retro-NS group, 72.1% (8.7%) for the IV-LID group, 54.5% (10.2%) for the Retro-LID group, 58.8% (4.0%) for the IV-L-ARG group, and 54.3% (4.0%) for the Retro-L-ARG group p < 0.005, Retro-LID and Retro-L-ARG versus Control, Retro-NS, and IV-LID; p < 0.03, IV-L-ARG versus control and Retro-NS). No significant difference in wall motion scores between groups was detected by echocardiography (p = 0.578). Conclusions. Retrograde delivery of lidocaine or L-arginine before reperfusion reduces infarct size without acutely affecting wall motion after 90 minutes of ischemia and 3 hours of reperfusion. Lidocaine must be present before reperfusion to have an effect, whereas L-arginine is beneficial if it is delivered at the time of reperfusion.

UR - http://www.scopus.com/inward/record.url?scp=0032076887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032076887&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(98)00186-6

DO - 10.1016/S0003-4975(98)00186-6

M3 - Article

C2 - 9594866

AN - SCOPUS:0032076887

VL - 65

SP - 1353

EP - 1359

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 5

ER -